Genistein reverses diminished T-cell signal transduction, induced by post-menopausal estrogen levels

Area of Science:

• Immunology
• Endocrinology
• Molecular Biology

Background:

• Estrogen deficiency, common in aging, impairs T-cell signaling.
• Key T-cell signaling components like CD3zeta, JAK3, and NFkappaB are affected.
• This loss impacts immune function during senescence.

Purpose of the Study:

• To investigate genistein's ability to reverse estrogen deficiency-induced T-cell signaling loss.
• To analyze genistein's effect on CD3zeta, JAK3, and NFkappaB expression and IL-2 production.
• To determine if genistein's effects differ between pre- and post-menopausal estrogen levels.

Main Methods:

• Jurkat 6.1 T cells were treated with varying estradiol (E(2)) levels (4 pg/mL and 40 pg/mL).
• Genistein's impact on CD3zeta, JAK3, and NFkappaB protein levels was assessed using Western immunoblotting.
• Gene expression and Interleukin-2 (IL-2) mRNA levels were quantified via real-time polymerase chain reaction (RT-PCR).

Main Results:

• Estrogen deficiency (4 pg/mL E(2)) significantly decreased CD3zeta, JAK3, and NFkappaB protein levels.
• Genistein treatment at post-menopausal E(2) levels restored these signaling proteins to levels seen at pre-menopausal E(2) concentrations.
• Genistein also reversed the diminished IL-2 mRNA levels observed under estrogen-deficient conditions.

Conclusions:

• Genistein effectively restores CD3zeta, NFkappaB, and JAK3 proteins and their corresponding mRNAs in vitro.
• These restorative effects occur under post-menopausal estrogen levels, mimicking aging-related deficiency.
• Genistein showed no significant impact at pre-menopausal estrogen levels, indicating a specific effect related to estrogen deficiency.